C-4


| Title | When lipids go solid: process strategies to enhance bioavailability in oral dosage forms |
|---|---|
| Date | 2026.08.25 (13:40 - 14:50) | Hall C Seminar room |
| Organization | Gattefossé |
| Speaker | Hongyi OUYANG, Regional Technical Sales Manager |
[Brief Introduction of Seminar]
Lipid excipients have a proven history of enhancing bioavailability of drugs through the improvement of solubility, permeability, and absorption. Being often liquid at room temperature, they are mainly formulated in liquid forms. That said, oral solid dosage forms such as tablets could benefit from the advantages of lipid excipients. This presentation will highlight different processes to incorporate lipid excipients in oral tablets or powders.
Key topics will include:
- Benefits of lipid excipients for bio-enhancement
- Market references
- Case studies highlighting formulation strategies and associated manufacturing processes.
[Brief Introduction of Speaker]
Hongyi holds a Bachelor’s degree in Pharmacy (1st class) and PhD in Pharmaceutical Technology from the National University of Singapore (NUS). During his research, he investigated on solid oral dosage formulations at GEA-NUS laboratory under the supervision of A/Prof Chan Lai Wah and A/Prof Paul Heng.
Prior to joining Gattefossé, Hongyi was a senior technical engineer at Merck Sharpe and Dohme (MSD) and formulation scientist at Clinuvel Pharmaceuticals.
At Gattefossé since 2022, Hongyi is responsible for technical marketing in the pharmaceutical division for the Asia Pacific region, covering oral, topical and rectal drug delivery. Additionally, he is responsible for sales in Thailand, Malaysia, Australia and New Zealand. Outside of work, Hongyi is a keen volleyball player and enjoys travelling.